Singh, J., Ferrante, N., Di, Niebes, P. & Tavella, D. N-acetylgalactosamine-6-sulfate sulfatase in man. J. Clin. Invest. 57, 1036–1040 (1976).
Google Scholar
Tomatsu, S. et al. Mucopolysaccharidosis type IVA (Morquio A Disease): clinical review and current treatment: a special review. Curr. Pharm. Biotechnol. 12, 931–945 (2011).
Google Scholar
Tomatsu, S. et al. Morquio A syndrome: diagnosis and current and future therapies. Pediatr. Endocrinol. Rev. 12, 141–151 (2014).
Byers, S., Vaidyanathan, S., L.K, A. & S.A, D.-R. Chondrogenesis and osteogenesis are delayed by MPS IVA keratan sulphate but not normal keratan sulphate. Mol. Genet. Metab. 123, 174 (2018).
Google Scholar
Montaño, A. M., Tomatsu, S., Gottesman, G. S., Smith, M. & Orii, T. International Morquio A Registry: Clinical manifestation and natural course of Morquio A disease. J. Inherit. Metab. Dis. 30, 165–174 (2007).
Google Scholar
Northover, H., Cowie, R. A. & Wraith, J. E. Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review. J. Inherit. Metab. Dis. 19, 357–365 (1996).
Google Scholar
Tomatsu, S. et al. Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A). Hum. Mutat. 26, 500–512 (2005).
Google Scholar
Dũng, V. C. et al. Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels. Mol. Genet. Metab. 110, 129–138 (2013).
Google Scholar
Fukuda, S. et al. Mucopolysaccharidosis IVA: Submicroscopic deletion of 16q24.3 and a novel R386C mutation of N-acetylgalactosamine-6-sulfate sulfatase gene in a classical morquio disease. Hum. Mutat. 7, 123–134 (1996).
Google Scholar
Lavery, C. & Hendriksz, C. Mortality in patients with Morquio syndrome A. JIMD Rep. 15, 59–66 (2014).
Google Scholar
Yangzi, J. & Tuan, R. S. Origin and function of cartilage stem/progenitor cells in osteoarthritis. Physiol. Behav. 176, 139–148 (2015).
Goldberg, A., Mitchell, K., Soans, J., Kim, L. & Zaidi, R. The use of mesenchymal stem cells for cartilage repair and regeneration: a systematic review. J. Orthop. Surg. Res. 12, 1–30 (2017).
Google Scholar
Tomatsu, S. et al. Enhancement of drug delivery: enzyme-replacement therapy for murine morquio a syndrome. Mol. Ther. 18, 1094–1102 (2010).
Google Scholar
Doherty, C. et al. Effect of enzyme replacement therapy on the growth of patients with Morquio A. J. Hum. Genet. 64, 625–635 (2019).
Google Scholar
Sanford, M. & Lo, J. H. Elosulfase alfa: first global approval. Drugs 74, 713–718 (2014).
Google Scholar
Tomatsu, S., Doherty, C. & Stapleton, M. Effect of enzyme replacement therapy on the growth of patients with Morquio syndrome type A. Mol. Genet. Metab. 126, S144 (2019).
Hendriksz, C. J. et al. Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study. J. Inherit. Metab. Dis. 37, 979–990 (2014).
Google Scholar
Hendriksz, C. J. et al. Multi-domain impact of elosufase alfa in Morquio A syndrome in the pivotal phase III trial. Mol. Genet. Metab. 114, 178–185 (2015).
Google Scholar
Mingozzi, F. & High, K. A. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat. Rev. Genet. 12, 341–355 (2011).
Google Scholar
Naldini, L. Gene therapy returns to centre stage. Nature 526, 351–360 (2015).
Google Scholar
Marcó, S., Haurigot, V. & Bosch, F. In vivo gene therapy for Mucopolysaccharidosis type III (Sanfilippo syndrome): a new treatment horizon. Hum. Gene Ther. 30, 1211–1221 (2019).
Tomatsu, S. et al. Mouse model on N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns−/−) produced by targeted disruption of the gene defective in Morquio A disease. Hum. Mol. Genet. 12, 3349–3358 (2003).
Google Scholar
Tomatsu, S. et al. Development of MPS IVA mouse (Galnstm(hC79S·mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase. Hum. Mol. Genet. 14, 3321–3335 (2005).
Google Scholar
Tomatsu, S. et al. Murine model (Galnstm(C76S)slu) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins. Mol. Genet. Metab. 91, 251–258 (2007).
Google Scholar
Sawamoto, K. et al. Liver-targeted AAV8 gene therapy ameliorates skeletal and cardiovascular pathology in a Mucopolysaccharidosis IVA murine model. Mol. Ther. 18, 50–61 (2020).
Google Scholar
Tessitore, A. et al. Biochemical, pathological, and skeletal improvement of mucopolysaccharidosis VI after gene transfer to liver but not to muscle. Mol. Ther. 16, 30–37 (2008).
Google Scholar
Larcher, T. et al. Characterization of dystrophin deficient rats: a new model for duchenne muscular dystrophy. PLoS ONE 9, e110371 (2014).
Lambert, L. J. et al. Increased trabecular bone and improved biomechanics in an osteocalcin-null rat model created by CRISPR/Cas9. Technol. DMM Dis. Model. Mech. 9, 1169–1179 (2016).
Google Scholar
Hansen, S. A. et al. Fischer-344 Tp53-knockout rats exhibit a high rate of bone and brain neoplasia with frequent metastasis. DMM Dis. Model. Mech. 9, 1139–1146 (2016).
Google Scholar
Yau, A. C. Y. & Holmdahl, R. Rheumatoid arthritis: identifying and characterising polymorphisms using rat models. DMM Dis. Model. Mech. 9, 1111–1123 (2016).
Google Scholar
Byrne, B. J. et al. Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapy. Ann. Transl. Med. 7, 290 (2019).
Google Scholar
Iyer, V. et al. Off-target mutations are rare in Cas9-modified mice. Nat. Methods 12, 479 (2015).
Google Scholar
Ayabe, S., Nakashima, K. & Yoshiki, A. Off- and on-target effects of genome editing in mouse embryos. J. Reprod. Dev. 65, 1–5 (2019).
Google Scholar
Montaño, A. M. et al. Effect of ‘attenuated’ mutations in mucopolysaccharidosis IVA on molecular phenotypes of N-acetylgalactosamine-6-sulfate sulfatase. J. Inherit. Metab. Dis. 30, 758–767 (2007).
Google Scholar
Jimenez, V. et al. In vivo adeno-associated viral vector-mediated genetic engineering of white and brown adipose tissue in adult mice. Diabetes 62, 4012–4022 (2013).
Google Scholar
Jimenez, V. et al. FGF21 gene therapy as treatment for obesity and insulin resistance. EMBO Mol. Med. 10, 1–24 (2018).
Google Scholar
Casana, E. et al. BMP7 overexpression in adipose tissue induces white adipogenesis and improves insulin sensitivity in ob/ob mice. Int. J. Obes. 45, 449–460 (2020).
Google Scholar
Ribera, A. et al. Biochemical, histological and functional correction of mucopolysaccharidosis Type IIIB by intra-cerebrospinal fluid gene therapy. Hum. Mol. Genet. 24, 2078–2095 (2015).
Google Scholar
Motas, S. et al. CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome). JCI Insight 1, 1–18 (2016).
Google Scholar
Roca, C. et al. Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID. Hum. Mol. Genet. 26, 1535–1551 (2017).
Google Scholar
Marcó, S. et al. Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC. DMM Dis. Model. Mech. 9, 999–1013 (2016).
Google Scholar
Fang-Kircher, S. G., Herkner, K., Windhager, R. & Lubec, G. The effects of acid glycosaminoglycans on neonatal calvarian cultures—a role of keratan sulfate in morquio syndrome. Life Sci. 61, 771–775 (1997).
De Santana Sarmento, D. J. et al. Mucopolysaccharidosis: radiographic findings in a series of 16 cases. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. 120, e240–e246 (2015).
Google Scholar
Colmenares-Bonilla, D., Vasconcelos-Martinez, M., Guerra-Jasso, J. & Ocampo-Perez, L. Guided growth may not be the best option for knee valgus deformity in adolescent patients with Morquio-A. Musculoskelet. Surg. 101, 113–118 (2017).
Google Scholar
Khan, S. et al. Mucopolysaccharidosis IVA and glycosaminoglycans. Mol. Genet. Metab. 120, 78–95 (2017).
Google Scholar
Peracha, H. et al. Molecular genetics and metabolism, special edition: diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA. Mol. Genet. Metab. 125, 18–37 (2018).
Google Scholar
Yasuda, E. et al. Pathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorder. Mol. Genet. Metab. 109, 301–311 (2013).
Google Scholar
Kampmann, C. et al. Heart and cardiovascular involvement in patients with mucopolysaccharidosis type IVA (Morquio-A syndrome). PLoS ONE 11, 1–12 (2016).
Google Scholar
De Franceschi, L., Roseti, L., Desando, G., Facchini, A. & Grigolo, B. A molecular and histological characterization of cartilage from patients with Morquio syndrome. Osteoarthr. Cartil. 15, 1311–1317 (2007).
Google Scholar
Kunieda, T. et al. Mucopolysaccharidosis type VI in rats: isolation of cDNAs encoding arylsulfatase B, chromosomal localization of the gene, and identification of the mutation. Genomics 29, 582–587 (1995).
Google Scholar
Tessitore, A., Pirozzi, M. & Auricchio, A. Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI. Pathogenetics 2, 4 (2009).
Google Scholar
Guevara-Morales, J. M. et al. Growth plate pathology in the mucopolysaccharidosis type VI rat model-an experimental and computational approach. Diagnostics 10, 360 (2020).
Forriol, F. & Shapiro, F. Bone development: interaction of molecular components and biophysical forces. Clin. Orthop. Relat. Res. 432, 14–33 (2005).
Morrison, S. J. & Scadden, D. T. The bone marrow niche for haematopoietic stem cells. Nature 505, 327–334 (2014).
Google Scholar
Knothe, M. L., Adamson, J. R., Tami, A. E. & Bauer, T. W. The osteocyte. Int. J. Biochem. Cell Biol. 36, 1–8 (2004).
Goldring, M. B. Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis. Ther. Adv. Musculoskelet. Dis. 4, 269–285 (2012).
Google Scholar
Bajpayee, A. G. & Grodzinsky, A. J. Cartilage-targeting drug delivery: can electrostatic interactions help? Nat. Rev. Rheumatol. 13, 183–193 (2017).
Google Scholar
Evans, C. H., Ghivizzani, S. C. & Robbins, P. D. Gene delivery to joints by intra-articular injection. Hum. Gene Ther. 29, 2–14 (2018).
Google Scholar
Tomatsu, S. et al. Enzyme replacement therapy in a murine model of Morquio A syndrome. Hum. Mol. Genet. 17, 815–824 (2008).
Google Scholar
Ruzo, A. et al. Liver production of sulfamidase reverses peripheral and ameliorates CNS pathology in mucopolysaccharidosis IIIA mice. Mol. Ther. 20, 254–266 (2012).
Google Scholar
Puzzo, F. et al. Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase. Sci. Transl. Med. 9, eaam6375 (2017).
Spalding, K. L. et al. Dynamics of fat cell turnover in humans. Nature 453, 783–787 (2008).
Google Scholar
White, U. & Ravussin, E. Dynamics of adipose tissue turnover in human metabolic health and disease HHS public access. Physiol. Behav. 62, 17–23 (2019).
Nakai, H. et al. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J. Virol. 75, 6969–6976 (2001).
Google Scholar
Wang, L. et al. AAV8-mediated hepatic gene transfer in infant rhesus monkeys (Macaca mulatta). Mol. Ther. 19, 2012–2020 (2011).
Google Scholar
Wang, L., Wang, H., Bell, P., McMenamin, D. & Wilson, J. M. Hepatic gene transfer in Neonatal mice by Adeno-associated virus serotype 8 vector. Hum. Gene Ther. 23, 533–539 (2012).
Google Scholar
Bortolussi, G. et al. Life-long correction of hyperbilirubinemia with a neonatal liver-specific AAV-mediated gene transfer in a lethal mouse model of Crigler-Najjar syndrome. Hum. Gene Ther. 25, 844–855 (2014).
Google Scholar
Colella, P., Ronzitti, G. & Mingozzi, F. Emerging issues in AAV-mediated in vivo gene therapy. Mol. Ther. 8, 87–104 (2018).
Google Scholar
Cotugno, G. et al. Long-term amelioration of feline mucopolysaccharidosis VI after AAV-mediated liver gene transfer. Mol. Ther. 19, 461–469 (2011).
Google Scholar
Piccolo, P., Rossi, A. & Brunetti-Pierri, N. Liver-directed gene-based therapies for inborn errors of metabolism. Expert Opin. Biol. Ther. 21, 229–240 (2020).
Google Scholar
Ayuso, E., Mingozzi, F. & Bosch, F. Production, purification and characterization of adeno-associated vectors. Curr. Gene Ther. 10, 423–436 (2010).
Google Scholar
